Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway
Publisher: Spandidos Publications
E-ISSN: 1791-3004|12|6|7869-7876
ISSN: 1791-2997
Source: Molecular Medicine Reports, Vol.12, Iss.6, 2015-01, pp. : 7869-7876
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract